about
Salmonella bongori provides insights into the evolution of the SalmonellaeCitrobacter rodentium is an unstable pathogen showing evidence of significant genomic fluxAn extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their disseminationFdeC, a Novel Broadly Conserved Escherichia coli Adhesin Eliciting Protection against Urinary Tract InfectionsNLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretionThe motor protein myosin 1G functions in FcγR-mediated phagocytosisCortactin recruitment by enterohemorrhagic Escherichia coli O157:H7 during infection in vitro and ex vivo.A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium.Involvement of the intermediate filament protein cytokeratin-18 in actin pedestal formation during EPEC infection.Molecular basis of antigenic polymorphism of EspA filaments: development of a peptide display technology.Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine originsDistribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates.RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium.The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals.Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors.The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivoNleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.Direct injection of functional single-domain antibodies from E. coli into human cells.EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics.Distribution of espM and espT among enteropathogenic and enterohaemorrhagic Escherichia coli.Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops.Legionella pneumophila secretes a mitochondrial carrier protein during infection.Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia.Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspHLegionella pneumophila strain 130b possesses a unique combination of type IV secretion systems and novel Dot/Icm secretion system effector proteins.The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentiumThe Dot/Icm effector SdhA is necessary for virulence of Legionella pneumophila in Galleria mellonella and A/J miceSubversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors.Use of Galleria mellonella as a model organism to study Legionella pneumophila infectionBinding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH.Citrobacter rodentium of mice and man.Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea.The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
P50
Q21131414-F46DBA4F-EB21-4941-B803-53D6F10853B4Q21131422-AE359036-7392-4B9D-A27B-F789271269AFQ24678382-DE2547A4-9268-48B2-97A3-72A4F2F23F73Q27678478-D62BA544-70D0-4CB8-94B9-05FF343CBB2DQ28512429-94A7CF2C-1AFB-4407-9004-4FD67CB2B0DDQ28585625-AF262C9F-96BB-49DC-9E16-3B99931E2626Q30157618-4BD1DCE3-F516-4F97-AD1A-FD3169BCEE1BQ30835474-19CAA0D2-6E55-4D95-8A02-C3EC074B02F9Q30916670-10E826FC-FB01-4298-AD09-1493CC83BBABQ33196595-2ED9C5DF-5389-4A8B-A168-F4B95155EB7FQ33215973-36FF8975-0EAE-494F-A681-C87B794D6EAFQ33347379-44972E45-4605-48BE-BAE4-70A8B967B201Q33363345-AEE16113-44D3-459B-9DC8-2BB0AB6CDF2BQ33365886-8D2A896F-45C2-4AC8-BEAB-4ED16010138FQ33518483-09575532-FE91-4A47-B7BB-15D2A6008163Q33526331-B1D7F25B-71B1-4ACF-93B3-47A228E4203BQ33528372-8F0012A3-F16C-40E7-817D-C5DF951BE106Q33582255-352BDF6F-E80F-417E-B406-57AAF16A25F0Q33621525-F79B232B-3F89-4590-B0AD-77085C039486Q33733678-1F836BA7-8B84-401F-B2FB-3C7A69E412B6Q33775617-63FAC8CB-53C1-4A0E-A952-3A5DDBB484F0Q33796480-2AF7555F-528A-40CD-84C9-5849FF1141FFQ33910262-BA8F1722-D698-40B2-A471-8DCFB522A6F6Q34117980-D72FDC3B-0188-4622-9876-FA0823602AD4Q34126309-E5D753B1-A3C0-49C5-9A10-993B4D5EA200Q34149331-F7B8D76C-19F1-433D-9BB4-8595578A61AEQ34177961-D2D50112-17A6-45E9-8B9E-EDBE936D23B3Q34198962-7371F089-81D1-42E0-9269-E23129EE4D89Q34247723-758BA0BA-BD38-4711-984F-E9BDF77154DFQ34291207-CFD352AA-1C0D-4A21-AAE1-45C4BB7ACF60Q34301058-B538E928-576F-48C7-A4CA-0F42639590CBQ34343225-E3E7C248-68CA-4420-9E80-57494E5B1B3CQ34358655-3665997E-BBB2-4AF5-8D1F-2B292615E925Q34389469-6B1B80AA-5979-49CE-AA1B-031CF16BA862Q34462401-32B765B2-00C6-4F08-86B5-295BA3E354ACQ34470352-936F9B62-2550-441F-AA39-5F32D1A98864Q34492843-E21ACF43-8BAF-469F-A62B-02391817CD26Q34506955-0807C5D2-0A30-4ECC-AFE7-71692A832012Q34596147-DB097690-FDA1-4683-A9F7-8C49BF4B73DDQ34739814-45BCC001-4DC6-4869-BE00-5B8E49482E3D
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Gad Frankel
@ast
Gad Frankel
@en
Gad Frankel
@es
Gad Frankel
@nl
type
label
Gad Frankel
@ast
Gad Frankel
@en
Gad Frankel
@es
Gad Frankel
@nl
prefLabel
Gad Frankel
@ast
Gad Frankel
@en
Gad Frankel
@es
Gad Frankel
@nl
P106
P21
P214
34154440064435341015
P31
P496
0000-0002-0046-1363
P7859
lccn-nb2018024949